Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study

Tumor mutation burden (TMB) is an independent indicator used to select patients sensitive to immunotherapy. The present study aimed to investigate the clinicopathological and molecular characteristics of patients with hypermutant lung cancer to identify an economical, simple and complementary method...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: Zhang, Hongbin, Wang, Yuan, Ji, Qiaoxia, Cai, Hongmei, Liang, Xiangcun, Xie, Jiong, Li, Hua, Wang, Jun, Zhu, Guiyun, Tian, Erpeng, Zhu, Lingling, Yuan, Mingming, Chen, Rongrong, Zhao, Min
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2021
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933761/
https://ncbi.nlm.nih.gov/pubmed/33692861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12590
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi